These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1080961)

  • 1. High dose methotrexate as a preoperative adjuvant in the treatment of epidermoid carcinoma of the head and neck. A feasibility study and clinical trial.
    Tarpley JL; Chretien PB; Alexander JC; Hoye RC; Block JB; Ketcham AS
    Am J Surg; 1975 Oct; 130(4):481-6. PubMed ID: 1080961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial adjuvant therapy in advanced squamous cell carcinoma of the head and neck employing weekly high dose methotrexate with leucovorin rescue.
    Pitman SW; Miller D; Weichselbaum R
    Laryngoscope; 1978 Apr; 88(4):632-8. PubMed ID: 306011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant methotrexate and leucovorin in head and neck squamous cancer. Two-year follow-up of a pilot project.
    Taylor SG; Bytell DE; DeWys WD; Applebaum E; Sisson GA
    Arch Otolaryngol; 1978 Nov; 104(11):647-51. PubMed ID: 309326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermoid carcinoma of head and neck: high-dose methotrexate in preoperative management.
    Arlen M
    N Y State J Med; 1979 Aug; 79(9):1384-9. PubMed ID: 291799
    [No Abstract]   [Full Text] [Related]  

  • 5. Predefinitive and postdefinitive chemotherapy for locally advanced squamous carcinoma of the head and neck.
    Kirkwood JM; Miller D; Weichselbaum R; Pitman SW
    Laryngoscope; 1979 Apr; 89(4):573-81. PubMed ID: 311882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved therapeutic index of methotrexate with "leucovorin rescue".
    Levitt M; Mosher MB; DeConti RC; Farber LR; Skeel RT; Marsh JC; Mitchell MS; Papac RJ; Thomas ED; Bertino JR
    Cancer Res; 1973 Jul; 33(7):1729-34. PubMed ID: 4541737
    [No Abstract]   [Full Text] [Related]  

  • 7. Surgical complications in patients with head and neck cancer receiving chemotherapy.
    Corey JP; Caldarelli DD; Hutchinson JC; Holinger LD; Taylor SG; Showel JL; Kooser JA
    Arch Otolaryngol Head Neck Surg; 1986 Apr; 112(4):437-9. PubMed ID: 3484960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck.
    Johnson JT; Wagner RL; Myers EN
    Cancer; 1996 Jan; 77(1):181-5. PubMed ID: 8630927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate-dose methotrexate in head and neck cancer.
    Advani SH; Mehta AR; Rao MR; Fakih AR; Sanghvi VD; Nair CN; Gopal R
    Oncology; 1981; 38(6):329-33. PubMed ID: 6975453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy.
    Machiels JP; Van Maanen A; Vandenbulcke JM; Filleul B; Seront E; Henry S; D'Hondt L; Lonchay C; Holbrechts S; Boegner P; Brohee D; Dequanter D; Louviaux I; Sautois B; Whenham N; Berchem G; Vanderschueren B; Fontaine C; Schmitz S; Gillain A; Schoonjans J; Rottey S
    Oncologist; 2016 Dec; 21(12):1416-e17. PubMed ID: 27903924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential methotrexate-5-fluorouracil treatment of squamous cell carcinoma of the head and neck.
    Ringborg U; Ewert G; Kinnman J; Lundqvist PG; Strander H
    Cancer; 1983 Sep; 52(6):971-3. PubMed ID: 6603896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methotrexate therapy.
    Bell R; Sullivan JR; Moon WJ; Hurley TH
    Med J Aust; 1977 Feb; 1(8):247-9. PubMed ID: 300460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
    Machiels JP; Haddad RI; Fayette J; Licitra LF; Tahara M; Vermorken JB; Clement PM; Gauler T; Cupissol D; Grau JJ; Guigay J; Caponigro F; de Castro G; de Souza Viana L; Keilholz U; Del Campo JM; Cong XJ; Ehrnrooth E; Cohen EE;
    Lancet Oncol; 2015 May; 16(5):583-94. PubMed ID: 25892145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck cancer. 3. Toxicity of 24-hour infusions of methotrexate (NSC-740) and protection by leucovorin (NSC-3590) in patients with epidermoid carcinomas.
    Lefkowitz E; Papac RJ; Bertino JR
    Cancer Chemother Rep; 1967 Sep; 51(5):305-11. PubMed ID: 4863189
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery.
    Ervin TJ; Kirkwood J; Weichselbaum RR; Miller D; Pitman SW; Frei E
    Laryngoscope; 1981 Jul; 91(7):1181-90. PubMed ID: 7017315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer.
    DeConti RC; Schoenfeld D
    Cancer; 1981 Sep; 48(5):1061-72. PubMed ID: 7023649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".
    Capizzi RL; DeConti RC; Marsh JC; Bertino JR
    Cancer Res; 1970 Jun; 30(6):1782-8. PubMed ID: 4248129
    [No Abstract]   [Full Text] [Related]  

  • 18. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
    Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen.
    Kirkwood JM; Canellos GP; Ervin TJ; Pitman SW; Weichselbaum R; Miller D
    Cancer; 1981 May; 47(10):2414-21. PubMed ID: 6974039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas--a prospective, randomized study.
    Rentschler RE; Wilbur DW; Petti GH; Chonkich GD; Hilliard DA; Camacho ES; Thorpe RB
    J Clin Oncol; 1987 Feb; 5(2):278-85. PubMed ID: 3806169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.